A new insight into the link between diabetes and cancer
Update time:2018-08-14 17:27:23 by SunLong

     Epidemiological studies have suggested that diabetes is linked to an increase risk of cancer. And high glucose levels may be a prevailing factor that contributes to the link between diabetes and cancer, but little is known about the molecular basis of this link.

     With more than four years, fortunately, a team from Fudan University published the reaearch result in Nature on July, 19. The paper named “Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer” reveals that metformin which is an anti-diabetic drug mediates tumor suppression.

     As we all know, the conversion of 5mC to 5hmC occurs through an oxidative reaction catalyzed by the ten-eleven translocation (TET) and the level of 5hmC can be a mark for the progress of cancer. AMPK is a key nutrient or energy sensor that is highly sensitive to glucose availability.

     In this study, the team found the molecular mechanism: increased glucose levels impede AMPK-mediated phosphorylation at serine 99, which results in the destabilization of TET2 followed by dysregulation of both 5hmC and the tumor suppressive function of TET2 in vitro and in vivo.


Copyright © 2007-2018 Sunlong Medical All Rights Reserved.